These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 970068)

  • 1. In vivo and in vitro experiments on relationships between PGA1 and glucose utilization.
    Torella R; Giugliano D; Giordano L; D'Onofrio F
    Acta Diabetol Lat; 1976; 13(1-2):40-6. PubMed ID: 970068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of vaso-inactive doses of PGA1 and PGE1 on insulin secretion in the rat.
    D'onofrio F; Torella R; Giugliano D; Improta L; Grazioli A
    Pharmacol Res Commun; 1977 May; 9(5):427-36. PubMed ID: 882586
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of PGA1 on utilization of glucose in rat.
    Torella R; Giordano L; D'onofrio F
    Farmaco Prat; 1975 Sep; 30(9):445-50. PubMed ID: 1183578
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of indole-3-alkanecarboxylic acids on glucose utilization in rats].
    Losert W; Kraaz W
    Arzneimittelforschung; 1975 Jun; 25(6):880-7. PubMed ID: 1100053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of exercise training on glucose homeostasis in normal and insulin-deficient diabetic rats.
    Goodyear LJ; Hirshman MF; Knutson SM; Horton ED; Horton ES
    J Appl Physiol (1985); 1988 Aug; 65(2):844-51. PubMed ID: 3049514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dichloroacetate on the metabolism of glucose, pyruvate, acetate, 3-hydroxybutyrate and palmitate in rat diaphragm and heart muscle in vitro and on extraction of glucose, lactate, pyruvate and free fatty acids by dog heart in vivo.
    McAllister A; Allison SP; Randle PJ
    Biochem J; 1973 Aug; 134(4):1067-81. PubMed ID: 4762752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-fatty acid interactions in the rat diaphragm in vivo.
    Schonfeld G; Kipnis DM
    Diabetes; 1968 Jul; 17(7):422-6. PubMed ID: 5666463
    [No Abstract]   [Full Text] [Related]  

  • 8. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
    Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
    Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of circulating insulin levels during the infusion of different prostaglandins in the rat.
    Saccà L; Perez G; Rengo F; Pascucci I; Condorelli M
    Acta Endocrinol (Copenh); 1975 Jun; 79(2):266-74. PubMed ID: 1173486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations.
    Rossetti L; DeFronzo RA; Gherzi R; Stein P; Andraghetti G; Falzetti G; Shulman GI; Klein-Robbenhaar E; Cordera R
    Metabolism; 1990 Apr; 39(4):425-35. PubMed ID: 2157941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism of centpiperalone-induced hypoglycemia.
    Mukherjee SS; Murthi PS; Mukherjee SK
    Acta Diabetol Lat; 1976; 13(1-2):8-19. PubMed ID: 788428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vivo interaction between gliclazide and glibenclamide and insulin on glucose disposal in the rat.
    Tanira MO; Furman BL
    Pharmacol Res; 1999 May; 39(5):349-56. PubMed ID: 10328992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal insulin sensitivity during the phase of glucose intolerance but insulin resistance at the onset of diabetes in the spontaneously diabetic BB rat.
    Baudon MA; Ferré P; Pénicaud L; Maulard P; Ktorza A; Castano L; Girard J
    Diabetologia; 1989 Dec; 32(12):839-44. PubMed ID: 2693164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of metformin on glucose uptake by isolated diaphragm from normal and diabetic rats.
    Frayn KN; Adnitt PI
    Biochem Pharmacol; 1972 Dec; 21(23):3153-62. PubMed ID: 4650637
    [No Abstract]   [Full Text] [Related]  

  • 15. Can plasma glucose and nonesterified fatty acid be regulators of glucose utilization in skeletal muscle?
    Narimiya M; Ohashi T; Kubokura T; Kaburagi M; Someya Y; Ikeda Y
    Endocr J; 1994 Apr; 41(2):197-206. PubMed ID: 7951569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of exercise upon serum factors and its secondary effect on glucose utilization by the resting muscle.
    Szabo O; Szabo AJ; Mahler RJ
    Horm Metab Res; 1972 May; 4(3):139-43. PubMed ID: 5044221
    [No Abstract]   [Full Text] [Related]  

  • 17. Lowering plasma free fatty acids with Acipimox mimics the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker diabetic fatty rats.
    Blachère JC; Pérusse F; Bukowiecki LJ
    Metabolism; 2001 Aug; 50(8):945-51. PubMed ID: 11474483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lisofylline, a novel anti-inflammatory agent, enhances glucose-stimulated insulin secretion in vivo and in vitro: studies in prediabetic and normal rats.
    Striffler JS; Nadler JL
    Metabolism; 2004 Mar; 53(3):290-6. PubMed ID: 15015139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenobarbital treatment enhances insulin-mediated glucose metabolism and improves lipid metabolism in the diabetic rat.
    Venkatesan N; Davidson MB; Simsolo RB; Kern PA
    Metabolism; 1994 Mar; 43(3):348-56. PubMed ID: 8139483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of hyperglycaemia and hypoinsulinaemia to the insulin resistance of streptozotocin-diabetic rats.
    Lisato G; Cusin I; Tiengo A; Del Prato S; Jeanrenaud B
    Diabetologia; 1992 Apr; 35(4):310-5. PubMed ID: 1516758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.